PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT): auditor change — Provectus BioPharma appoints CBIZ as new auditor following Marcum acquisition

PROVECTUS BIOPHARMACEUTICALS, INC.

Marcum LLP resigned as independent auditor on April 15, 2025, due to its acquisition by CBIZ.
Audit Committee approved engagement of CBIZ CPAs P.C. as successor auditor on the same date.
No disagreements or reportable events occurred with Marcum during 2024, 2023, or through resignation date.
Audit reports for fiscal years 2024 and 2023 were unmodified and not qualified.
Marcum letter agreeing with statements filed as Exhibit 16.1.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Marcum LLP resigned as auditor of PROVECTUS BIOPHARMACEUTICALS, INC..

Action: resignation
Auditor: Marcum LLP
Successor: CBIZ CPAs P.C.

Exact text from the filing

Marcum resigned as the independent registered public accounting firm of the Company

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

PROVECTUS BIOPHARMACEUTICALS, INC. engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

ovember 1, 2024, CBIZ CPAs P.C. (“CBIZ”) acquired the attest business of Marcum LLP (“Marcum”), and substantially

View on SEC.gov

Browse all auditor changes →

PROVECTUS BIOPHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001641172-25-004995

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.